首页> 外国专利> new oligosaccharid containing 14 aminosteroidverbindungen and new diastereoselektive aminosteroid process chemistry

new oligosaccharid containing 14 aminosteroidverbindungen and new diastereoselektive aminosteroid process chemistry

机译:含有14个氨基甾类化合物的新寡糖和新的非对映选择性氨基甾类化学

摘要

The present invention relates to oligosaccharide-containing 14-aminosteroid compounds and the pharmaceutically-acceptable acid salts or esters thereof of the general formula: CHEM wherein a) R1 is (i) COOR5, where R5 is hydrogen, a 1-6 carbon lower alkyl ; a 1-6 carbon lower alkyl substituted by an amino group; an arylalkyl or heteroarylalkyl or a carbocyclic ring, or (ii) CHR6OH, where R6 is a hydrogen atom or 1-6 carbon lower alkyl group, or (iii) COR''', where R''' is hydrogen; 1-6 carbon lower alkyl; 1-6 carbon lower alkyl substituted amino; amino or dialkylamino; and b) R2 is -NR7R8, where R7 and R8, which may be the same or different, are hydrogen atoms or a 1-6 carbon lower alkyl ; and c) R3 is (i) an oligosaccharide sugar residue having the following structure: CHEM where R9 is hydrogen; methyl; hydroxy; carboxy; acetoxy; arylalkyloxy; heteroarylalkyloxy or benzoxy; R10 is hydrogen; methyl; carboxy; acetoxy; arylalkyloxy; heteroarylalkyloxy; benzoxy or hydroxy; R11 is oxygen; wherein further when R11 is a substituent on the terminal monosaccharide sugar residue; R11 is OH; methyl; acetoxy; arylalkyloxy; heteroarylalkyloxy; and R12 is a hydrogen; methyl; methylhydroxymethyl; or acetoxymethyl; or (ii) an oligosaccharide sugar residue having the following structure: CHEM where R14 and R15, which may be the same or different, are hydrogen; 1-6 carbon lower alkyl; heteroarylalkyl; arylalkyl; heteroaryl or aryl; R17 can be hydrogen; hydroxy; acetoxy or benzoxy; R18 and R19 are hydroxy; acetoxy and benzoxy; or (iii) an oligosaccharide residue having the following structure: CHEM where R14 and R15, which may be the same or different, are hydrogen; 1-6 carbon lower alkyl; heteroaryl alkyl; arylalkyl; heteroaryl or aryl; R14a is oxygen; wherein further when R14a is a substituent on the terminal monosaccharide sugar residue; R14a must be hydroxy; methyl; acetoxy; arylalkyloxy or heteroarylalkyloxy; and d) R4 is (i) OH, or (ii) H, or (iii) OR13, where R13 is a monosaccharide sugar residue; acetoxy; benzoxy; arylalkyl or heteroarylalkyl; and e) Z is (i) -CH-, where a and b are single bonds, or (ii) =C, where either a or b is a double bond. The present invention also relates to a process for introducing an amino group at the 14-position on a steroid nucleus wherein said amino group is diasteroselectively introduced onto the 14-position of the steroid nucleus via an iodoisocyanate addition comprising the steps of: a) adding the iodoisocyanate to the 14-15 position double bond on the steroid nucleus; and b) dehalogenation; and c) isocyanate conversion to the amine moiety on the 14-position of the steroid nucleus.
机译:含寡糖的14-氨基甾类化合物及其药学上可接受的酸盐或酯,其通式为:其中a)R1为(i)COOR5,其中R5为氢,1-6碳低级烷基;被氨基取代的1-6个碳的低级烷基;芳基烷基或杂芳基烷基或碳环,或(ii)CHR6OH,其中R6为氢原子或1-6个碳的低级烷基,或(iii)COR''',其中R'''为氢; 1-6个碳的低级烷基; 1-6个碳的低级烷基取代的氨基;氨基或二烷基氨基; b)R2是-NR7R8,其中R7和R8可以相同或不同,是氢原子或1-6个碳的低级烷基; c)R3为(i)具有以下结构的寡糖残基:其中R9为氢;甲基;羟基羧基乙酰氧基芳基烷氧基;杂芳基烷氧基或苯氧基; R10是氢;甲基;羧基乙酰氧基芳基烷氧基;杂芳基烷氧基;苯氧基或羟基; R11是氧;其中当R11是末端单糖糖残基上的取代基时; R11为OH;甲基;乙酰氧基芳基烷氧基;杂芳基烷氧基; R 12为氢。甲基;甲基羟甲基;或乙酰氧基甲基; (ii)具有以下结构的寡糖残基:其中R14和R15可以相同或不同,为氢;或1-6个碳的低级烷基;杂芳基烷基;芳烷基;杂芳基或芳基; R17可以是氢;羟基乙酰氧基或苯氧基; R18和R19是羟基;乙酰氧基和苯氧基; (iii)具有以下结构的寡糖残基:其中R14和R15可以相同或不同,为氢;或1-6个碳的低级烷基;杂芳基烷基;芳烷基;杂芳基或芳基; R14a是氧;其中当R14a为末端单糖糖残基上的取代基时; R14a必须是羟基;甲基;乙酰氧基芳基烷氧基或杂芳基烷氧基; d)R4为(i)OH或(ii)H或(iii)OR13,其中R13为单糖残基;乙酰氧基苯氧基芳基烷基或杂芳基烷基; e)Z为(i)-CH-,其中a和b为单键,或(ii)= C,其中a或b为双键。本发明还涉及在甾体核的14位上引入氨基的方法,其中所述氨基通过碘异氰酸酯加成非对映选择性地引入甾体核的14位上,包括以下步骤:a)加入碘异氰酸酯在类固醇核上的14-15位双键; b)脱卤; c)将异氰酸酯转化为甾体核的14位上的胺部分。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号